IWM
TLX

IHT Wealth Management’s Telix Pharmaceuticals TLX Stock Holding History

IHT Wealth Management’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240K Sell
25,035
-250
-1% -$1.9K 0.01% 1103
2025
Q4 		$189K Sell
25,285
-923
-4% -$8.88K ﹤0.01% 1137
2025
Q3 		$251K Buy
26,208
+12,968
+98% +$159K 0.01% 1015
2025
Q2 		$213K Buy
+13,240
New +$222K 0.01% 1060

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $6.97B AUM 29.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

IHT Wealth Management's TLX Position: Q1 2026 in Review

IHT Wealth Management reduced its Telix Pharmaceuticals (TLX) stake by 0.99% in Q1 2026, selling an estimated $1.9K and leaving 25,035 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #1103.

IHT Wealth Management first reported a position in TLX in Q2 2025 and has held it in 4 quarters since. The position peaked at $251K in Q3 2025. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • IHT Wealth Management held 25,035 shares of Telix Pharmaceuticals worth $240K as of Q1 2026.
  • IHT Wealth Management sold 250 Telix Pharmaceuticals shares in Q1 2026, an estimated $1.9K.
  • Telix Pharmaceuticals made up 0.01% of IHT Wealth Management's portfolio in Q1 2026, its #1103 holding.
  • IHT Wealth Management first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • IHT Wealth Management's Telix Pharmaceuticals position peaked at $251K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.